Rhythm Biosciences Statistics
Total Valuation
ASX:RHY has a market cap or net worth of AUD 34.68 million. The enterprise value is 31.49 million.
| Market Cap | 34.68M |
| Enterprise Value | 31.49M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:RHY has 353.87 million shares outstanding. The number of shares has increased by 22.10% in one year.
| Current Share Class | 353.87M |
| Shares Outstanding | 353.87M |
| Shares Change (YoY) | +22.10% |
| Shares Change (QoQ) | +12.61% |
| Owned by Insiders (%) | 14.96% |
| Owned by Institutions (%) | 7.01% |
| Float | 255.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.92 |
| PB Ratio | 9.53 |
| P/TBV Ratio | 12.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.61 |
| Quick Ratio | 3.36 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -78.28 |
Financial Efficiency
Return on equity (ROE) is -276.00% and return on invested capital (ROIC) is -129.49%.
| Return on Equity (ROE) | -276.00% |
| Return on Assets (ROA) | -96.19% |
| Return on Invested Capital (ROIC) | -129.49% |
| Return on Capital Employed (ROCE) | -156.79% |
| Weighted Average Cost of Capital (WACC) | 6.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 9.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.42 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 56.81 |
| Average Volume (20 Days) | 237,400 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:RHY had revenue of AUD 1.74 million and -5.93 million in losses. Loss per share was -0.02.
| Revenue | 1.74M |
| Gross Profit | 1.33M |
| Operating Income | -5.86M |
| Pretax Income | -5.93M |
| Net Income | -5.93M |
| EBITDA | -5.67M |
| EBIT | -5.86M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 3.44 million in cash and 247,980 in debt, with a net cash position of 3.19 million or 0.01 per share.
| Cash & Cash Equivalents | 3.44M |
| Total Debt | 247,980 |
| Net Cash | 3.19M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 3.64M |
| Book Value Per Share | 0.01 |
| Working Capital | 2.72M |
Cash Flow
In the last 12 months, operating cash flow was -5.23 million and capital expenditures -25,797, giving a free cash flow of -5.26 million.
| Operating Cash Flow | -5.23M |
| Capital Expenditures | -25,797 |
| Depreciation & Amortization | 203,568 |
| Net Borrowing | -156,854 |
| Free Cash Flow | -5.26M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 76.29% |
| Operating Margin | -336.37% |
| Pretax Margin | -340.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:RHY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.10% |
| Shareholder Yield | -22.10% |
| Earnings Yield | -17.10% |
| FCF Yield | -15.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |